Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes.

Chee-Kiat Tan,Xue-Shi Luo,Benjamin Shao-Kiat Ong, Liang Lin,Kwong-Hoe Ng

JGH OPEN（2023）

Cited 0|Views13
No score
Abstract
The subsidy decision led to increased accessibility to patients and intended changes in clinical practice. Sofosbuvir-velpatasvir was also clinically effective in the real world. These findings augur well for the continued eradication of chronic hepatitis C infection in Singapore.
More
Translated text
Key words
chronic hepatitis C,clinical practice,patient outcomes,real‐world impact,sofosbuvir–velpatasvir
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined